These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38627980)

  • 1. Loss of OVOL2 in Triple-Negative Breast Cancer Promotes Fatty Acid Oxidation Fueling Stemness Characteristics.
    Lu R; Hong J; Fu T; Zhu Y; Tong R; Ai D; Wang S; Huang Q; Chen C; Zhang Z; Zhang R; Guo H; Li B
    Adv Sci (Weinh); 2024 Jun; 11(24):e2308945. PubMed ID: 38627980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance.
    Wang T; Fahrmann JF; Lee H; Li YJ; Tripathi SC; Yue C; Zhang C; Lifshitz V; Song J; Yuan Y; Somlo G; Jandial R; Ann D; Hanash S; Jove R; Yu H
    Cell Metab; 2018 Jan; 27(1):136-150.e5. PubMed ID: 29249690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FABP4-mediated lipid metabolism promotes TNBC progression and breast cancer stem cell activity.
    Yu L; Wei W; Lv J; Lu Y; Wang Z; Cai C
    Cancer Lett; 2024 Nov; 604():217271. PubMed ID: 39306229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HRD1 inhibits fatty acid oxidation and tumorigenesis by ubiquitinating CPT2 in triple-negative breast cancer.
    Guo X; Wang A; Wang W; Wang Y; Chen H; Liu X; Xia T; Zhang A; Chen D; Qi H; Ling T; Piao HL; Wang HJ
    Mol Oncol; 2021 Feb; 15(2):642-656. PubMed ID: 33207079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation.
    Wright HJ; Hou J; Xu B; Cortez M; Potma EO; Tromberg BJ; Razorenova OV
    Proc Natl Acad Sci U S A; 2017 Aug; 114(32):E6556-E6565. PubMed ID: 28739932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eucannabinolide, a novel sesquiterpene lactone, suppresses the growth, metastasis and BCSCS-like traits of TNBC via inactivation of STAT3.
    Zhu Z; Yuan J; Xu X; Wei Y; Yang B; Zhao H
    Neoplasia; 2021 Jan; 23(1):36-48. PubMed ID: 33217668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting DCLK1 attenuates tumor stemness and evokes antitumor immunity in triple-negative breast cancer by inhibiting IL-6/STAT3 signaling.
    Liu H; Yan R; Xiao Z; Huang X; Yao J; Liu J; An G; Ge Y
    Breast Cancer Res; 2023 Apr; 25(1):43. PubMed ID: 37069669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT3-induced HLA-F-AS1 promotes cell proliferation and stemness characteristics in triple negative breast cancer cells by upregulating TRABD.
    Wu D; Jia H; Zhang Z; Li S
    Bioorg Chem; 2021 Apr; 109():104722. PubMed ID: 33618253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PDSS1-Mediated Activation of CAMK2A-STAT3 Signaling Promotes Metastasis in Triple-Negative Breast Cancer.
    Yu TJ; Liu YY; Li XG; Lian B; Lu XX; Jin X; Shao ZM; Hu X; Di GH; Jiang YZ
    Cancer Res; 2021 Nov; 81(21):5491-5505. PubMed ID: 34408002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Milk Protein Alpha-Casein Suppresses Triple Negative Breast Cancer Stem Cell Activity Via STAT and HIF-1alpha Signalling Pathways in Breast Cancer Cells and Fibroblasts.
    Garner KEL; Hull NJ; Sims AH; Lamb R; Clarke RB
    J Mammary Gland Biol Neoplasia; 2019 Sep; 24(3):245-256. PubMed ID: 31529195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HN1L Promotes Triple-Negative Breast Cancer Stem Cells through LEPR-STAT3 Pathway.
    Liu Y; Choi DS; Sheng J; Ensor JE; Liang DH; Rodriguez-Aguayo C; Polley A; Benz S; Elemento O; Verma A; Cong Y; Wong H; Qian W; Li Z; Granados-Principal S; Lopez-Berestein G; Landis MD; Rosato RR; Dave B; Wong S; Marchetti D; Sood AK; Chang JC
    Stem Cell Reports; 2018 Jan; 10(1):212-227. PubMed ID: 29249663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma.
    Qi XK; Han HQ; Zhang HJ; Xu M; Li L; Chen L; Xiang T; Feng QS; Kang T; Qian CN; Cai MY; Tao Q; Zeng YX; Feng L
    Theranostics; 2018; 8(8):2202-2216. PubMed ID: 29721073
    [No Abstract]   [Full Text] [Related]  

  • 13. Tocilizumab potentiates cisplatin cytotoxicity and targets cancer stem cells in triple-negative breast cancer.
    Alraouji NN; Al-Mohanna FH; Ghebeh H; Arafah M; Almeer R; Al-Tweigeri T; Aboussekhra A
    Mol Carcinog; 2020 Sep; 59(9):1041-1051. PubMed ID: 32537818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.
    Serrano-Oviedo L; Nuncia-Cantarero M; Morcillo-Garcia S; Nieto-Jimenez C; Burgos M; Corrales-Sanchez V; Perez-Peña J; Győrffy B; Ocaña A; Galán-Moya EM
    Cell Oncol (Dordr); 2020 Jun; 43(3):431-444. PubMed ID: 32166583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential combination of docetaxel with a SHP-1 agonist enhanced suppression of p-STAT3 signaling and apoptosis in triple negative breast cancer cells.
    Liu CY; Chen KF; Chao TI; Chu PY; Huang CT; Huang TT; Yang HP; Wang WL; Lee CH; Lau KY; Tsai WC; Su JC; Wu CY; Chen MH; Shiau CW; Tseng LM
    J Mol Med (Berl); 2017 Sep; 95(9):965-975. PubMed ID: 28578456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryptotanshinone alleviates liver fibrosis via inhibiting STAT3/CPT1A-dependent fatty acid oxidation in hepatic stellate cells.
    Li Z; Zheng Y; Zhang L; Xu E
    Chem Biol Interact; 2024 Aug; 399():111119. PubMed ID: 38936533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TCOF1 upregulation in triple-negative breast cancer promotes stemness and tumour growth and correlates with poor prognosis.
    Hu J; Lai Y; Huang H; Ramakrishnan S; Pan Y; Ma VWS; Cheuk W; So GYK; He Q; Geoffrey Lau C; Zhang L; Cho WCS; Chan KM; Wang X; Rebecca Chin Y
    Br J Cancer; 2022 Jan; 126(1):57-71. PubMed ID: 34718356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic regulation of invasion by STAT3 in triple negative breast cancer.
    McDaniel JM; Varley KE; Gertz J; Savic DS; Roberts BS; Bailey SK; Shevde LA; Ramaker RC; Lasseigne BN; Kirby MK; Newberry KM; Partridge EC; Jones AL; Boone B; Levy SE; Oliver PG; Sexton KC; Grizzle WE; Forero A; Buchsbaum DJ; Cooper SJ; Myers RM
    Oncotarget; 2017 Jan; 8(5):8226-8238. PubMed ID: 28030809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quercetin: a silent retarder of fatty acid oxidation in breast cancer metastasis through steering of mitochondrial CPT1.
    Ruidas B; Sur TK; Das Mukhopadhyay C; Sinha K; Som Chaudhury S; Sharma P; Bhowmick S; Majumder R; Saha A
    Breast Cancer; 2022 Jul; 29(4):748-760. PubMed ID: 35511410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYCL promotes the progression of triple‑negative breast cancer by activating the JAK/STAT3 pathway.
    Jiang H; Li X; Wang W; Hu Y; Ren D
    Oncol Rep; 2022 Nov; 48(5):. PubMed ID: 36177900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.